# Takotsubo Syndrome: The First Non-Acute Proteomic Analysis by Remote Dried Blood Microsampling

**Authors:** Paul Marano, Kirstin Washington, Blandine Chazarin, Niveda Sundararaman, Koen Raedschelders, Jenna Maughan, Okezi Obrutu, Benita Tjoe, Romana Herscovici, Prizzi Moy, Chrisandra Shufelt, Thomas Rutledge, Alexander Polyak, Sandy Joung, Yunxian Liu, Susan Cheng, Janet Wei, Jennifer E. Van Eyk, C. Noel Bairey Merz

PMC · DOI: 10.1007/s12265-026-10752-0 · Journal of Cardiovascular Translational Research · 2026-02-27

## TL;DR

This study is the first to analyze non-acute blood proteins in Takotsubo syndrome patients, revealing potential long-term biological changes linked to the condition.

## Contribution

The first non-acute proteomic analysis of Takotsubo syndrome using remote dried blood microsampling.

## Key findings

- Agnostic clustering distinguished TTS patients from controls based on proteomic profiles.
- Differentially regulated proteins were enriched in complement activation, nitric oxide signaling, and antioxidant pathways.
- Findings suggest persistent cardiomyopathy or predisposition mechanisms in non-acute TTS.

## Abstract

Takotsubo syndrome (TTS) is an under-recognized form of acute-onset heart failure typically precipitated by stress. While recovery of cardiac function is described over the course of weeks, adverse outcomes after apparent recovery are increasingly recognized. However, the pathophysiology of non-acute manifestations remains poorly understood. We used mass-spectrometry-based discovery proteomics from remotely collected non-acute dried blood microsamples to perform a case-control study in 62 participants with a prior TTS episode (median of 2.24 years prior to sample collection) and 47 reference controls. We quantified 398 unique proteins, and found that agnostic clustering techniques showed separation between TTS and reference control samples. This represents the first proteomic characterization of non-acute TTS. Pathway analysis of the 52 differentially regulated proteins demonstrated enrichment of proteins involved in complement activation, nitric oxide signaling, and with antioxidant activity. These enriched pathways may be suggestive of a persistent cardiomyopathy resulting from or predisposing to TTS.

The online version contains supplementary material available at 10.1007/s12265-026-10752-0.

## Linked entities

- **Diseases:** Takotsubo syndrome (MONDO:0019018), heart failure (MONDO:0005252)

## Full-text entities

- **Genes:** C1QB (complement C1q B chain) [NCBI Gene 713] {aka C1QD2}, CDC5L (cell division cycle 5 like) [NCBI Gene 988] {aka CDC5, CDC5-LIKE, CEF1, PCDC5RP, dJ319D22.1}, ABCF1 (ATP binding cassette subfamily F member 1) [NCBI Gene 23] {aka ABC27, ABC50}, STK10 (serine/threonine kinase 10) [NCBI Gene 6793] {aka LOK, PRO2729}, PSMA2 (proteasome 20S subunit alpha 2) [NCBI Gene 5683] {aka HC3, MU, PMSA2, PSC2}, PLG (plasminogen) [NCBI Gene 5340] {aka HAE4}, TPM3 (tropomyosin 3) [NCBI Gene 7170] {aka CAPM1, CFTD, CMYO4A, CMYO4B, CMYP4A, CMYP4B}, TXNDC5 (thioredoxin domain containing 5) [NCBI Gene 81567] {aka ENDOPDI, ERP46, HCC-2, HCC2, PDIA15, STRF8}, C4B (complement C4B (Chido/Rodgers blood group)) [NCBI Gene 721] {aka C4B1, C4B12, C4B3, C4B5, C4BD, C4F}, FSCN1 (fascin actin-bundling protein 1) [NCBI Gene 6624] {aka HSN, SNL, p55}, COL14A1 (collagen type XIV alpha 1 chain) [NCBI Gene 7373] {aka UND}, C8A (complement C8 alpha chain) [NCBI Gene 731], KLKB1 (kallikrein B1) [NCBI Gene 3818] {aka KLK3, PKK, PKKD, PPK}, C1QC (complement C1q C chain) [NCBI Gene 714] {aka C1Q-C, C1QD3, C1QG}, VTN (vitronectin) [NCBI Gene 7448] {aka V75, VN, VNT}, TBCA (tubulin folding cofactor A) [NCBI Gene 6902], C4BPA (complement component 4 binding protein alpha) [NCBI Gene 722] {aka C4BP, PRP}, C1QA (complement C1q A chain) [NCBI Gene 712] {aka C1QD1}, F12 (coagulation factor XII) [NCBI Gene 2161] {aka HAE3, HAEX, HAF}, PTX3 (pentraxin 3) [NCBI Gene 5806] {aka TNFAIP5, TSG-14}, A2M (alpha-2-macroglobulin) [NCBI Gene 2] {aka A2MD, CPAMD5, FWP007, S863-7}, SERPINF2 (serpin family F member 2) [NCBI Gene 5345] {aka A2AP, AAP, ALPHA-2-PI, API, PLI, alpha2AP}, CFH (complement factor H) [NCBI Gene 3075] {aka AHUS1, AMBP1, ARMD4, ARMS1, CFHL3, FH}, DDB1 (damage specific DNA binding protein 1) [NCBI Gene 1642] {aka DDBA, UV-DDB1, WHIKERS, XAP1, XPCE, XPE}, H19-ICR (H19/IGF2 imprinting control region) [NCBI Gene 105259599] {aka BWS, H19-DMD, IC1, ICR1, ICR1-DMR, SRS1}, S100A6 (S100 calcium binding protein A6) [NCBI Gene 6277] {aka 2A9, 5B10, CABP, CACY, PRA, S10A6}, HBB (hemoglobin subunit beta) [NCBI Gene 3043] {aka CD113t-C, ECYT6, beta-globin}, S100A9 (S100 calcium binding protein A9) [NCBI Gene 6280] {aka 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG}, ZNF318 (zinc finger protein 318) [NCBI Gene 24149] {aka HRIHFB2436, TZF, ZFP318}, F13A1 (coagulation factor XIII A chain) [NCBI Gene 2162] {aka F13A}, LUM (lumican) [NCBI Gene 4060] {aka LDC, SLRR2D}, Lum (lumican) [NCBI Gene 17022] {aka Ldc, SLRR2D}, LAMB1 (laminin subunit beta 1) [NCBI Gene 3912] {aka CLM, LIS5, LKBMH, LUCAO}, KNG1 (kininogen 1) [NCBI Gene 3827] {aka BDK, BK, HAE6, HK, HMWK, KNG}, CLIC4 (CLIC family member 4) [NCBI Gene 25932] {aka CLIC4L, H1, MTCLIC, huH1, p64H1}, APOA1 (apolipoprotein A1) [NCBI Gene 335] {aka AMYLD3, HPALP2, apo(a)}, GSTP1 (glutathione S-transferase pi 1) [NCBI Gene 2950] {aka DFN7, FAEES3, GST3, GSTP, GSTP1-1, HEL-S-22}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, GC (GC vitamin D binding protein) [NCBI Gene 2638] {aka DBP, DBP-maf, DBP/GC, GRD3, Gc-MAF, GcMAF}, FAM76B (family with sequence similarity 76 member B) [NCBI Gene 143684], EMILIN1 (elastin microfibril interfacer 1) [NCBI Gene 11117] {aka ATBFS, EMI, EMILIN, HMN10, HMND10, gp115}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, IGKV@ (immunoglobulin kappa variable cluster) [NCBI Gene 3519] {aka IGKV, IGKV1, IGKV1@, IGKV2, IGKV2@, IGKV3}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, C2 (complement C2) [NCBI Gene 717] {aka ARMD14, CO2}, AZGP1 (alpha-2-glycoprotein 1, zinc-binding) [NCBI Gene 563] {aka ZA2G, ZAG}, SERPINA1 (serpin family A member 1) [NCBI Gene 5265] {aka A1A, A1AT, AAT, PI, PI1, PRO2275}, TAGLN (transgelin) [NCBI Gene 6876] {aka SM22, SM22-alpha, SMCC, TAGLN1, TGLN, WS3-10}, CLU (clusterin) [NCBI Gene 1191] {aka AAG4, APO-J, APOJ, CLI, CLU1, CLU2}, ASS1 (argininosuccinate synthase 1) [NCBI Gene 445] {aka ASS, CTLN1}, THRB (thyroid hormone receptor beta) [NCBI Gene 7068] {aka C-ERBA-2, C-ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH}, ESD (esterase D) [NCBI Gene 2098] {aka FGH}, KLK4 (kallikrein related peptidase 4) [NCBI Gene 9622] {aka AI2A1, ARM1, EMSP, EMSP1, KLK-L1, PRSS17}, CFI (complement factor I) [NCBI Gene 3426] {aka AHUS3, ARMD13, C3BINA, C3b-INA, FI, IF}, ACTR2 (actin related protein 2) [NCBI Gene 10097] {aka ARP2}, PRKDC (protein kinase, DNA-activated, catalytic subunit) [NCBI Gene 5591] {aka DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC}, PSPHP1 (phosphoserine phosphatase pseudogene 1) [NCBI Gene 8781] {aka CO9, PSPHL}, FKBP5 (FKBP prolyl isomerase 5) [NCBI Gene 2289] {aka AIG6, FKBP51, FKBP54, P54, PPIase, Ptg-10}, APOM (apolipoprotein M) [NCBI Gene 55937] {aka G3a, HSPC336, NG20, apo-M}, LRG1 (leucine rich alpha-2-glycoprotein 1) [NCBI Gene 116844] {aka HMFT1766, LRG}
- **Diseases:** Inflammation (MESH:D007249), Cardiac Fibrosis (MESH:D005355), cardiogenic shock (MESH:D012770), diabetes (MESH:D003920), malignancy (MESH:D009369), anxiety (MESH:D001007), left ventricular systolic dysfunction (MESH:D018487), cardiac structural and functional abnormalities (MESH:C566527), chest pain (MESH:D002637), Cardiomyopathy (MESH:D009202), hypertension (MESH:D006973), complement (MESH:D007153), Coronavirus (MESH:D018352), TTS (MESH:D054549), pulmonary arterial hypertension (MESH:D000081029), acute myocardial infarction (MESH:D009203), cardiovascular disease (MESH:D002318), dilated cardiomyopathy (MESH:D002311), heart failure (MESH:D006333), infarction (MESH:D007238), depression (MESH:D003866), hypertrophic cardiomyopathy (MESH:D002312), cardiac remodeling (MESH:D020257), coronary artery disease (MESH:D003324), cardiac conditions (MESH:D006331)
- **Chemicals:** aspirin (MESH:D001241), Nitric Oxide (MESH:D009569), P2Y12 receptor inhibitors (-), hydrogen sulfide (MESH:D006862), catecholamine (MESH:D002395), isoproterenol (MESH:D007545), sodium hydrosulfide (MESH:C025451), sphingolipid (MESH:D013107), reactive oxygen species (MESH:D017382)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12948850/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12948850/full.md

---
Source: https://tomesphere.com/paper/PMC12948850